TCT-17 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 3-Year Clinical and Imaging Results

TCT-17 Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 3-Year Clinical and Imaging Results

Patients receiving the study device were analyzed for multiple clinical endpoints including: device and procedure success; Major Adverse Cardiac Events (MACE), a composite endpoint of cardiac death, target vessel MI, or clinically-indicated target lesion revascularization (CI-TLR); Target Vessel Rev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2015-10, Vol.66 (15), p.B7-B7
Hauptverfasser: Verheye, Stefan, Schofer, Joachim, Maeng, Michael, Witzenbichler, Bernhard, Botelho, Roberto, Ormiston, John A, Costa, Ricardo A, Costa, Jose d, Chamié, Daniel, Castro, Juliana P, Abizaid, Andrea, John, Yan, Bbhat, Vinayak, Morrison, Lynn, Toyloy, Sara, Abizaid, Alexandre
Format: Artikel
Sprache:eng
Schlagworte:
Angioplasty
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Medical imaging
Stents
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Patients receiving the study device were analyzed for multiple clinical endpoints including: device and procedure success; Major Adverse Cardiac Events (MACE), a composite endpoint of cardiac death, target vessel MI, or clinically-indicated target lesion revascularization (CI-TLR); Target Vessel Revascularization, (CI-TVR) and stent thrombosis assessed at 1, 6 and annually to 5 years.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2015.08.061